目的 考察5种临床常用平喘药分别与吸入用盐酸氨溴索溶液的配伍稳定性。方法 将硫酸特布他林雾化液、吸入用异丙托溴铵溶液、吸入用布地奈德混悬液、丙酸氟替卡松雾化吸入用混悬液及吸入用丙酸倍氯米松混悬液分别与吸入用盐酸氨溴索溶液按照临床剂量配伍组合。通过检测外观、pH和液相色谱峰面积,考察其配伍稳定性。结果 7种配伍组合在6 h内,外观均无明显变化,pH值稳定,相对标准偏差(RSD)均在2%内。建立的高效液相色谱法中6个成分的线性关系良好,专属性强,精密度、重复性及稳定性的RSD均小于2%,回收率良好,符合方法学要求,配伍组合中各成分6 h内峰面积变化RSD均小于2%。结论 吸入用盐酸氨溴索溶液可与5种临床常用平喘药稳定配伍,符合临床用药安全要求。
Abstract
OBJECTIVE To investigate the compatible stability of five commonly used anti-asthmatic drugs and ambroxol hydrochloride solution for inhalation. METHODS According to the common clinical concentrations, terbutaline sulfate nebulizer solution, ipratropium bromide solution and budesonide suspension for inhalation, fluticasone propionate nebuliser suspension and beclometasone dipropionate suspension for inhalation were combined with ambroxol hydrochloride solution for inhalation. The appearance, pH value and peak areas of high performance liquid chromatography were measured to investigate the compatible stability. RESULTS No significant changes in the appearance and pH of all 7 combinations within 6 h, and the RSDs are all within 2%. In the established high performance liquid chromatography method, the linearity and specificity of the six components were satisfactory; the RSDs of precision, repeatability and stability were less than 2%,the spiked recovery rates were good, which all met the methodological requirements. The RSD of each component in the combinations within 6 h was less than 2%. CONCLUSION The ambroxol hydrochloride solution for inhalation could be stably compatible with five commonly used clinical antiasthmatic drugs, which could meet the requirements of clinical safety.
关键词
盐酸氨溴索溶液 /
配伍稳定性 /
硫酸特布他林雾化液 /
异丙托溴铵溶液 /
布地奈德混悬液 /
丙酸氟替卡松雾化混悬液 /
丙酸倍氯米松混悬液 /
吸入剂
{{custom_keyword}} /
Key words
ambroxol hydrochloride solution /
compatible stability /
terbutaline sulfate nebulizer solution /
ipratropium bromide solution /
budesonide suspension /
fluticasone propionate nebuliser suspension /
beclometasone dipropionate suspension /
inhalation
{{custom_keyword}} /
中图分类号：
R917
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ZHANG Y Z. Study on ambroxol hydrochloride sustained-release Suspension[D]. Wuhan:Hubei University of Chinese Medicine, 2014.
[2] YU F, LI C, LIU M, et al. Aerosol inhalation of ambroxol hydrochloride combined with terbutaline can promote recovery of children with severe pneumonia[J]. AM J Transel Res, 2021, 13 (5): 5019-5026.
[3] LI X, WU X, GAO Y, et al. Apoptosis-linked antifungal effect of ambroxol hydrochloride by cystolic calcium concentration disturbance in resistant Candida albicans[J]. Sci China Life Sci, 2019, 62 (12): 1601-1604.
[4] CHEN Z W, HUANG X Q, YE M Q, et al. Clinical effect of ambroxol hydrochloride injection in the adjuvant treatment of bronchopneumonia[J]. Chin J Clin Ration Drug Use(临床合理用药杂志), 2021, 14 (17): 63-65.
[5] WANG L X. Effect of atomized inhalation of ambroxol hydrochloride on curative effect and sleep quality in elderly patients with chronic bronchitis[J]. World J Sleep Med(世界睡眠医学杂志), 2021, 8(6): 934-935.
[6] CHEN T. Clinical efficacy of ambroxol hydrochloride atomization inhalation therapy in the treatment of elderly chronic bronchitis[J]. Electron J Clin Med Lit(临床医药文献电子杂志), 2019, 6(83): 29.
[7] LI Y N. To observe the effect of ambroxol hydrochloride aerosol inhalation in the treatment of senile chronic bronchitis[J]. Guide Chin Med(中国医药指南), 2021, 19(19): 97-98.
[8] YANG M. Therapeutic effect of nebulized inhalation of ambroxol hydrocholride and budesonide in neonates with pneumonia[J]. Smart Healthc(智慧健康), 2019, 5(6): 44-45.
[9] ZHANG Y L. Effects of interferon gamma combined with ambroxol hydrochloride injection inhalation on signs improvement and quality of life in patients with acute attack of chronic bronchitis[J]. Harbin Med J(哈尔滨医药), 2018, 38(1): 10-11.
[10] CAO R J, LI X S, LI Q, et al. Compatible stability of ambroxol hydrochloride injection with three bronchodilators[J]. China Pharm(中国药业), 2021, 30(18): 45-50.
[11] MA Y L, ZHAO F, PANG G X, et al. Preparation and evaluation of levosalbutamol sulfate-ambroxol hydrochloride dry powder inhalation[J]. Chin Pharm J(中国药学杂志), 2017, 52(23): 2104-2111.
[12] XIAN M L. Clinical observation on ambroxol hydrochloride combined with ipratropium bromide atomization inhalation in the treatment of senile ventilator associated pneumonia[J]. Chin J Mod Drug Appl(中国现代药物应用), 2017, 11 (5): 58-60.
[13] XIAO X X, FANG J S, HONG M J. Effect of beclomethasone propionate combined with ambroxol hydrochloride atomization inhalation in children with pneumonia[J]. China Pract Med(中国实用医药), 2019, 14 (14): 130-131.
[14] WANG Y G. Effect of compound preparation of salmeterol and fluticasone propionate powder on immune function in patients with COPD and pulmonary tuberculosis[J]. Chin J Ration Drug Use(中国合理用药探索), 2019, 16(8): 62-64, 67.
[15] DU G, ZHAO J, PU S H, et al. Expert consensus on rational drug use of aerosol inhalation therapy (2019)[J]. Her Med(医药导报), 2019, 38(2): 135-146.
[16] FAN Q Q, ZHANG B, LI D K, et al. Current clinical application of ambroxol hydrochloride injection and consideration on the rational drug use[J]. Chin Pharm J(中国药学杂志), 2015, 50(9): 816-820.
[17] WU M H, LIU Q, TENG X M. Research progress of aerosol inhalation[J]. Chin J New Clin Med(中国临床新医药), 2018, 11(11): 1167-1171.
[18] SHEN Y C, WEN F Q. Interpretation of expert consensus on clinical management of airway mucus hypersecretion in chronic airway inflammatory diseases in the People's Republic of China[J]. Chin J Pract Intern Med(中国实用内科杂志), 2016, 36 (2): 131-132.
[19] WANG Y J, CHEN Y G, LV C Z, et al. An updated Chinese consensus statement on stroke-associated pneumonia 2019[J]. Chin J Stroke(中国卒中杂志), 2019, 14 (12): 1251-1262.
[20] CHEN Q, CHEN Z M, CHENG H J, et al. Chinese expert consensus on the diagnosis and treatment of chronic wet cough in children[J]. Chin J Pract Pediatr(中国实用儿科杂志), 2019, 34 (4): 256-264.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
中央高水平医院临床科研业务费资助(BJ-2021-211)
{{custom_fund}}
PDF(969 KB)
